ASSESSMENT OF  SERUM PARAOXONASE-1 ENZYME ACTIVITY, MALONDIALDEHYDE AND VITAMIN-C IN ORAL PREMALIGNANCIES by Param, Kar et al.
 21 
 
Original Article 
International Journal of Clinical and Biomedical Research. © 2018  Sumathi Publications.  
This is an Open Access article which permits unrestricted non-commercial use, provided the original work is properly cited.  
INTRODUCTION 
Oral premalignant lesions also known as potential-
ly malignant disorders are a group of disease or 
syndromes which if left untreated can lead to oral 
cancer [1]. This way it carries a great significance in 
Indian perspective, as oral cancer shares about 13-
16% of the cancer load of India [2]. It is seen that 
maximum oral cancers are squamous cell cancers, 
where some of them can arise from an apparently 
normal mucosa while others arise from some clinically 
obvious premalignant lesions [3]. In Indian context, 
in contrary to that of western countries, these dis-
eases are seen to be maximally coexistent with life 
style related problems like smoking, chewing tobacco, 
paan, betel nut, ghutkha, alcohol drinking and so on 
[4]. These known addiction substances can induce 
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oxidative stress by several modes. Interplay of oxida-
tive stress and chronic inflammation is one of them 
[5]. Serum PON-1 is a part of body's complex antioxi-
dant system that is known to confer antioxidant and 
antiatherogenic role to HDL [6]. A greater prevalence 
of PON-1 192 glutamine allele and reduced PON-1 
activity was seen in Oral Squamous Cell Carcinoma 
Patients (OSCC) and in Turkish Lung cancer patients [7, 
8]. These findings in OSCC suggest that PON-1activity 
may be a contributing factor to the progression of 
Oral Premalignancies too. 
The present study was therefore undertaken to under-
stand the molecular etiopathogenesis of oral premalig-
nancies by assessing the extent of lipid peroxidation 
and oxidative stress level through estimation of PON-1 
activity, MDA and vitamin C levels.  
MATERIALS AND METHODS 
Study design: This analytical case control observational 
study.  
Ethics approval: The protocol of this study was ap-
proved by the Institutional Human Ethics Committee. 
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Study location: The study was carried out in Dept. of 
Biochemistry in collaboration with Dept. of ENT at 
MGIMS, Sewagram. 
Sample selection: Patients with oral premalignant le-
sions and diseased controls were recruited after ob-
taining their written consent in regional language. 
Sample size: A total number of 63 samples.  
Inclusion criteria: Cases of premalignancies were cho-
sen totally on clinical diagnosis. They  were  recruited  
within  the  age  group  of  20  to  60years  without  any 
sex differentiation. Controls were taken considering 
the exclusion criteria  
Exclusion criteria: with no history of smoking and any 
past or present history of oral premalignancy were 
excluded from the study.  
Grouping: Subjects were mainly divided into two group: 
Group 1: Control. 
Group 2: Test group, clinically according to the severi-
ty each of them were again divided into different 
subgroups. OSMF cases were divided into clinical 
Grades of I, II &  III   and  OL  group  was  divided  in  
Homogenous  and  Non-Homogenous clinically. 
Methodology: Clinical and demographic data  was  
collected  regarding  their  smoking  habits and  other  
risk  behaviors  by proforma method.    
About 10 ml venous blood was collected from par-
ticipants in plain (for serum) and EDTA (for plas-
ma) vials. Serum was used for PON-1, MDA esti-
mation and plasma for Vitamin C.   
Estimation of PON- 1 Activity: Serum Paraoxonase 1 
activity was measured spectrophotometrically 
(ELICO) according to Gan et al. (1991) [9] with some 
modifications. Using Paraoxon (Paraoxon Ethyl of 
Sigma-Eldrich) as a substrate, concentration of the 
product p-nitrophenol was measured at 420 nm using 
molar extinction coefficient of 18,290 M-1 cm-1 at pH 
10. 
Estimation of Malondialdehyde (MDA): Serum MDA 
level was measured according to Buege & Aust SD 
(1978) [10]. MDA in serumreacts with thiobarbituric 
acid (TBA) (Sigma-Eldrich) to form a colored product, 
absorbance of which was measured spectrophotomet-
rically (ELICO) at 535 nm. The malondialdehyde con-
centration of the sample was calculated using the 
extinction coefficient of 1.56 x 105 M-1 cm-1. 
Estimation of Vitamin C: Plasma Vitamin C was meas-
ured according to Aye Kyaw, (1978) [11]. The acid 
phototungstate used in this method serves as plas-
ma protein precipitant as well as ascorbic acid ex-
tractant and color developing agent, as it gets reduced 
to tungstate blue by ascorbic acid. The blue color was 
measured in spectrophotometer (ELICO) at 700 nm. 
Absorbancewas read is read against blank, constituted 
with distilled water (instead of plasma), and subjected 
to all treatments simultaneously as test samples. 
For every set, a standard (Sigma-Eldrich) and blank 
are run through the procedure. 
Statistical analysis: For comparison in the groups we 
used unpaired t test, ANOVA, TUKEY HSD and for cor-
relation analysis we used Pearson’s Correlation Test. A 
‘p-value’ less than 0.05 was considered significant. 
RESULTS 
OSMF cases were divided into clinical Grades of I, II &  
III  (after  Anil  K  Ghom) [12]  and  OL  group  was  di-
vided  in  Homogenous  and  Non-Homogenous clini-
cally (after S Warnakulasuriya et al) [13]. 
There were 5, 7 & 8 subjects in the subgroups of 
Grades of I, Grade II & Grade III OSMF accordingly.  
Likewise, in Oral Leukoplakia there were 12 subjects 
in Non-homogenous subgroup and 10 subjects in Ho-
mogenous leukoplakia subgroups. Tobacco related 
addiction like Paan, Kharra, tobacco chew, smoking 
were the common addiction habits in both the 
premalignant groups with a mean age addicting of 6 
years. 
Mean serum PON-1 activity was significantly lower in 
Leucoplakia then OSMF (P<0.05), OSMF than controls 
(P<0.05) and Leucoplakia than controls (P<0.05) Like-
wise, Vitamin C level was also significantly lower in 
Leucoplakia than OSMF (P<0.05), OSMF than controls 
(p<0.05) and Leucoplakia than controls (P<0.05). But in 
contrast the serum MDA level were significantly  higher  
in  the  same  respective  groups  that  is  in  Leuco-
plakia  than  OSMF (P<0.05), OSMF than control 
(P<0.05) and Leucoplakia than control (P<0.05).  
DISCUSSION 
The most commonly found PMD are OSMF, OL and 
erythroplakia [14]. In our study we got two groups of 
premalignancies i.e. OSMF and Oral Leukoplakia. Clini-
cally, on inspection of oral mucosa, one can find a 
chronic fibrotic change in OSMF and white patches 
that cannot be characterized otherwise in Oral Leu-
koplakia. The malignant transformation rate for OSMF 
is 7.6% in17 years of follow up and for OL it is about 
13.6% globally [15, 16]. In India, according to 
various studies, there is a strikingly varied prevalence 
of both OSMF (0.03 to 3.2%) and OL (0.2% to 4.9%)  
[17,18]. 
Oral   Premalignancies are found to share common 
etiological   insults   and   common geographical distri-
bution like Oral Cancers in India [19]. Thus, in these 
backgrounds mentioned and moreover, the absence 
of an established etiopathogenic mode and inability to 
predict a malignant transformation, makes oral 
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premalignancy an important candidate to be investi-
gated in line of oral cancer, at least in Indian perspec-
tive. 
Talking about molecular mechanisms behind, oxi-
dative stress is a known culprit behind cancerogen-
esis and amongst the various mechanisms that our 
body has developed to fight back, Paraoxonase -1 
enzyme is one of them. PON -1, a hydrolytic enzyme 
with a wide range of substrate, gathered a significant 
interest as a protein that is mainly responsible for 
most of the antioxidant properties of High Density 
Lipoprotein (HDL). Its beneficial role against athero-
sclerosis is already well documented. PON-1 gene is 
mainly expressed in liver and it is transported in the 
circulation in association with lipoproteins and get 
delivered to the multiple other sites who doesn’t syn-
thesise PON-1 by themselves. PON-1 by interacting 
with Apo-A binds to HDL and gets circulated along the 
blood circulation. An increased accumulation of PON-
1 in the media and intima of the aorta in atheroscle-
rotic arties is attributed to macrophages which also 
connects the link of PON-1 to lipid peroxidation. 
Thus, it is seen that  PON-1  has  a  capacity  to  pro-
tect  our  cells  from  lipid  peroxidation [20].  By vir-
tue of antioxidant property PON-1 enzyme achieved a 
heavily suspected role in pathogenesis of OSCC, which 
makes it an important candidate to be investigated in 
Oral Premalignancies too. In our study, wefound a 
significant decrease in serum PON-1 activity in both 
the premalignancies than the control group (Table1). 
Even in oral leucoplakia group mean serum PON-1 
activity was significantly lower (P<0.05) than OSMF 
(Table1). A gradual decrease in the mean serum PON-
Parameters 
Controls 
(Mean ± SD) 
OSMF 
(Mean + SD) 
Oral  
Leukoplakia 
(Mean + SD) 
PON-1 
Activity (unit/ ml) 
313.02 ± 87.93 265.00 ± 26.64* 170.39 ± 33.42*£ 
MDA (µmol/L) 0.7645 ± 0.178 2.34 ± 0.67* 2.94 ± 0.64*£ 
Vitamin C (mg/dl) 3.14 ± 0.395 2.09 ± 0.55* 1.51 ± 0.47*£ 
Mean Value in different stages 
Disease Subgroups 
PON-1 
activity(unit/ml) 
MDA (µmol/L) Vitamin C (mg/dl) 
OSMF 
Grade I 278.99 ± 27.24 1.113 ± 0.417 2.625 ± 0.25 
Grade II 269.69 ± 27.19 1.7181 ± 0.219 2.2 ± 0.434 
Grade III 251.63 ± 22.94 2.4844 ± 0.235 1.6571 ± 0.475 
OL 
Homogenous 184.24 ± 33.02 2.58 ± 0.482 1.9 ± 0.326 
Non- homoge-
nous 
159.73 ± 30.77 3.3192 ± 0.522 1.2061 ± 0.305 
Control   313.02 ± 87.93 0.7645 ± 0.178 3.14 ± 0.395 
Table 1. The mean serum PON -1 activity, MDA concentration and plasma Vitamin C level in the test groups.  
Table 2. Mean value in different disease subgroups 
Statistically Significant (P<0.05) in comparison to Control (*), OSMF (£) 
  OSMF P value 
Oral 
Leukoplakia 
P value 
Pon1 
Grade I 
Grade II 0.645 
Homogenous vs 
Non-homogenous 
0.030 Grade III 0.119 
Grade II Grade III 0.372 
MDA 
Grade I 
Grade II <0.05 
Homogenous vs 
Non-homogenous 
0.004 Grade III <0.05 
Grade II Grade III <0.05 
Vitamin C 
Grade I 
Grade II 0.308 
Homogenous vs 
Non-homogenous 
0.001 Grade III <0.05 
Grade II Grade III <0.05 
Table 3: Inter-comparison of PON-1, MDA & Vitamin C Level in Different clinical grades of OSMF & Oral Leu-
koplakia by TUKEY HSD  
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1 activity in clinical grades of OSMF from Grade I to 
Grade III was observed, though the difference was not 
statistically significant (Table2, Table 3). Probably this 
is due to small sample size of these subgroups. How-
ever, interestingly, there was a statistically significant 
decrease (P<0.05) in  PON-1  activity from  Homoge-
nous  to  Non- Homogenous Leukoplakia subgroups 
(P<0.05) (Table2, Table 3).Smokers are known to have 
a significant decrease in PON-1 activity along with 
higher propensity to have oxidized Low-Density Lipo-
protein (LDL) and HDL. But the molecular mecha-
nism is not clear till now [21]. 
Table 4. Correlation between serum PON-1 activity 
with MDA and Vitamin C in the study groups 
 
Fig 1:  Scatter  Plot  showing  Correlation  between  
serum  PON-1  activity  with  MDA  and Vitamin C 
The addiction habits of our study population substan-
tiate our findings of decreased serum PON-1 activity, 
andpositively indicates that the decrease in the pro-
tective antioxidant role of PON-1 is playing some role 
in their progression. 
Reactive Oxygen species degrades polyunsaturated 
lipids forming malondialdehyde. This reactive alde-
hyde by its electrophilic properties produces ad-
vanced lipoxidation end products (ALE) by causing 
toxic stress in cells. This ALE is widely used as a bi-
omarker to measure lipid peroxidation related oxida-
tive stress in organisms.In this study, we found a grad-
Correlation in Pon-1 and 
MDA 
Correlation in Pon-1 and 
Vitamin C 
Group 
Pearson 
Correlation 
Group 
Pearson 
Correlation 
OSMF -0.421 OSMF 0.025 
leukoplakia -0.156 leukoplakia 0.522 
Control 0.002 Control -0.073 
ual increase in the serum MDA level in both the 
Oral PMDs groups as compared to controls. This 
increase in MDA level was also significantly in-
creased (P<0.05) in Oral Leukoplakia than OSMF 
(Table 1). Our findings were consistent with that of 
RH Chole et al [22]. On further analysis there were 
statistically significant increase (P<0.05) in the MDA 
level within all the clinical grades OSMF according to 
severityand from Homogenous to Non-Homogenous 
Leukoplakia (Table2, Table3). Our study correlates 
nicely with S Gupta et al [23] for OSMF cases and 
Metgud R & Bajaj S [24] for Oral Leukoplakia cases. A 
finding like this indicates the strong role of lipid perox-
idation behind the progression of OSMF and Oral leu-
koplakia from normal mucosal epithelium. 
Frie et al showed that plasma ascorbic acid is the 
only endogenous antioxidant which is able to com-
pletely protect the lipids from detectable peroxidative 
damage induced by aqueous peroxyl radicals [25]. It 
acts as a co-antioxidant that regenerates α-tocopherol 
from α- tocopheroxy radical generated during the 
scavenging of free radicals. In this study we have esti-
mated the antioxidant vitamins in plasma expecting 
that circulating vitamins are better reflected than their 
tissue/cellular levels. We found a statistically signifi-
cant    decrease in the mean plasma Ascorbic Acid in 
Oral PMD from controls (Table 1). The decrease was 
also significant in OL than OSMF (P<0.05) (Table 1). 
Except for Grade I and Grade II OSMF 
Vitamin C level was significantly lower (P<0.05) from 
less severe to more severe clinical subgroup of 
premalignancies (Table 2, Table 3). Our overall findings 
are in agreement with those of Dr. Sarita Basu [26]. 
Vitamin C by its oxidizing properties reacts with 
superoxide produced from normal cellular metabo-
lism; this in turn inhibits formation of nitrosamines 
during protein digestion and prevents damage to DNA 
and other cellular proteins. But very little is docu-
mented regarding the ability of Ascorbic Acid to main-
tain the oral mucosal integrity. In a study conducted 
by V. Touvinen et al, a significant higher percentage of 
Oral Leukoplakia than any other Oral Premalignancies 
were found in Vitamin C deficient cases [27]. 
Again, in OSMF, it was found that there was an in-
crease in the production of highly cross linked insolu-
ble collagen Type I, increase loss of soluble procolla-
gen type III and collagen type VI. This cross-linking is 
attributed to the upregulation of lysyl oxidase, playing 
a crucial role in the development of Grade II OSMF 
from Grade I [28]. A decrease of such in plasma Vita-
min C level probably indicates to its more utilization 
towards collagen synthesis. This hypothesis is also 
strengthened by our findings of significant reduction 
of plasma vitamin C level in oral premalignancies than 
controls. PON-1 is also found to be negatively corre-
lating with MDA and positively correlating with Vita-
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min C in both OSMF and Oral Leukoplakia groups. In 
OSMF, PON-1 had fair negative correlation with MDA 
and in Leukoplakia it was rather fair positively corre-
lated with Vitamin C. Despite these minor differences, 
it can be aptly said that overall finding suggests that 
decreased PON-1 activity was associated with in-
creased oxidative stress parameters (increased MDA, 
decreased Vitamin C) in Oral Premalignant Disease 
patients.   
CONCLUSION  
From this finding it can be envisaged and concluded 
that the interplay between decreased serum PON-1 
activity and increased in oxidative stress do play some 
role in the etiopathogenesis and progression of Oral 
Premalignant Diseases. Further large-scale studies for 
genetic susceptibility, PON-1 gene polymorphism, PON-
1 activity in non -tobacco related oral Premalignancies 
are needed to substantiate our findings. 
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